Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Vigamox (Moxifloxacin Hydrochloride) Prescribers for Ocular Infections: Ophthalmologists (US)(?)

Council Members in this Study Group: 18

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Barry Schechter, MD, Director of Corneal and External Diseases, Florida Eye Microsurgical Institute, Inc. Barry Schechter, MD
Director of Corneal and External Diseases
Florida Eye Microsurgical Institute, Inc.

Barry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal, refractive, and cataract surgery, and glaucoma....

Vincent de Luise, MD, Head of Cornea Service, Opticare Eye Health Center P.C.Vincent de Luise, MD
Head of Cornea Service
Opticare Eye Health Center P.C.

Vincent de Luise, MD, FACS, is Assistant Clinical Professor of Ophthalmology at Yale University and the University of Connecticut, and Head of the Cornea Service at OptiCare Eye Health Center. Dr. de Luise is also the Education Chair of the Connecticut Society of Eye Physicians. He is an ophthalmologist...

Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CCMark Packer, MD
Clinical Associate Professor of Ophthalmology
OREGON HEALTH & SCIENCE UNIVERSITY - CC

Mark Packer, MD, FACS, is Clinical Associate Professor of Ophthalmology at Oregon Health & Sciences University. He is also in private practice with Drs. Fine and Hoffman in Eugene, OR. His research focuses on refractive surgery and intraocular lens technology. Dr. Packer is also the principal investigator...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
By Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC

The Visian ICL (Implantable Collamer Lens) is an exquisitely precise technology for the correction of high degrees of nearsightedness -- much higher than the reach of laser refractive surgery such as LASIK and PRK.  Given the price of the ICL and the intraocular surgey required for its...

By Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: Glaxo Seeks Guidance From Health Systems | online.wsj.com

"He who pays the fiddler calls the tune."  Here's an example of the fiddler pro-actively asking the guy in the room with the deepest pocket what he'd like to hear.  If it's not something in the current repertoire, the fiddler seems willing to learn.  However, by the time he's got...

By Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com

The media reporting on the FDA hearings on LASIK has generally highlighted unhappy patients' stories and the comments of FDA officials and panel members.  However, The Washington Post's Lauran Neergard has written an insightful article that foresees an important future trend in refractive surgery....

By Barry Schechter, MD, Director of Corneal and External Diseases, Florida Eye Microsurgical Institute, Inc.
Analysis of: Bausch & Lomb announces acquisition of eyeonics | www.osnsupersite.com

With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.

The market for eye drops for the treatment of open angle glaucoma is huge. Profit potential for pharmaceutical companies, however, is limited by the time period that they are afforded patent protection. Combigan, the just approved brimonidine/timolol combination therapy, affords Allergan new patent...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • President
  • Physician - Division Head

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880